about
Association between smoking and blood pressure: evidence from the health survey for England.Influence of hormone replacement therapy on C-reactive protein: population-based data.Determinants of vascular phenotype in a large childhood population: the Avon Longitudinal Study of Parents and Children (ALSPAC).Adiposity and cardiovascular risk factors in a large contemporary population of pre-pubertal childrenAdipose and height growth through childhood and blood pressure status in a large prospective cohort study.Association of Retinopathy and Retinal Microvascular Abnormalities With Stroke and Cerebrovascular Disease.An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: a randomized placebo-controlled trial (AARDVARK).Multicentre observational study of surgical system failures in aortic procedures and their effect on patient outcomes.An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: a randomised placebo-controlled trial (AARDVARK).Time trends in childhood and adolescent obesity in England from 1995 to 2007 and projections of prevalence to 2015.Comparison of methods for modelling a count outcome with excess zeros: application to Activities of Daily Living (ADL-s).Persistent regional variation in treatment of hypertension.A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus.Comparison of the Prognostic Usefulness of the European Society of Cardiology and American Heart Association/American College of Cardiology Foundation Risk Stratification Systems for Patients With Hypertrophic Cardiomyopathy.Birth weight and blood pressure in childhood: results from the Health Survey for England.Are valved holding chambers (VHCs) interchangeable? An in vitro evaluation of VHC equivalence.Prediction equations for normal and low lung function from the Health Survey for England.Age trajectories of quality of life among older adults: results from the English Longitudinal Study of Ageing.Hypertension management in England: a serial cross-sectional study from 1994 to 2011.Changes in the FEV₁/FVC ratio during childhood and adolescence: an intercontinental study.Childhood Obesity and Vascular PhenotypesRandomized Crossover Trial of the Impact of Morning or Evening Dosing of Antihypertensive Agents on 24-Hour Ambulatory Blood PressureNo evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, pImproving lipid profiles and increasing use of lipid-lowering therapy in England: results from a national cross-sectional survey - 2006Continued Improvement in Hypertension Management in EnglandLettre ouverte aux membres du comité GOLD – 13 juillet 2010Rationale and design of the randomized multicentre His Optimized Pacing Evaluated for Heart Failure (HOPE-HF) trial.The need to change the method for defining mild airway obstructionImplementation of pay for performance policy in EnglandOpen letter: the need to change the method for defining mild airway obstruction
P50
Q32069517-576EAC1C-26DA-4923-9BD6-A8ADFC69D1FCQ33185952-36F33AD7-F372-4E33-B4B5-00F86F303BCDQ34030500-BCC29ABF-FA7C-48BD-9B47-2B183FDD8F8FQ34404169-6CD83B7C-C1D2-43D1-B0A1-A2820B8D89D3Q36193476-74E977A4-5F92-48B4-85FE-D7884D0E43FAQ37371458-D04E5A60-6732-442D-A53E-8D4C2D029C07Q37529894-4745FF07-DC74-4760-9513-8BE272B8C9CCQ39457154-340BB27F-7892-4E7F-8EB3-D5E0D1F6AEDEQ39527059-CD393F32-F244-42B4-A0C8-C903790C911FQ39911618-4C885B1F-7EA1-4716-83B2-9F2AB1CF18E9Q43319524-AD45B7C3-E43E-41AA-A6E9-E7E20B8C122CQ44830922-C8F232B9-57C9-442B-9583-212F05892203Q45835949-EAD3FEA5-9C5C-4921-B819-9273CBAD4AEFQ47371803-44F5F62F-7CA5-476E-AC7E-8FF4259DDEFBQ47399624-343816E2-DE73-4082-84C9-A4F9D2BC5766Q47450423-26FDFC62-A7CB-451B-AEA6-77EE3539F6D5Q47997306-2D276007-8F15-4B1D-8F9C-0808138D8C95Q49009648-011565B8-A5D2-4F43-9A0A-7C8E46802671Q51248014-CB8D66D0-C4A0-46AF-A4E5-255FCFB5C023Q51710332-9F7DEA85-D82B-4D69-9652-F43B01289930Q57105202-D02A1E78-B88F-4226-BF19-96B82F1EAE04Q57819116-5C3541CE-2314-4ACC-B74D-DA4FD846CF85Q59822600-2E1FD250-7E65-4FAD-9AA4-A2CD2CE8CBCEQ61045724-C237B9B7-F104-4057-924B-14A19B35628DQ61045747-BAC7FD7D-73F0-45D4-B780-39AC8B3E427EQ61910661-713D481F-8F4C-445A-8A49-D18DD6E59B66Q64942610-98548B19-8166-42D1-ADC7-ED4CC8803AE3Q83491533-09438FC3-988B-4A38-9EEA-51EED7040CC4Q83917108-67148CE7-6B99-4040-A05A-D95FEB1F0230Q84983879-5304E8C1-D26A-4B99-8B74-10C83F32CDA3
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
E Falaschetti
@ast
E Falaschetti
@en
E Falaschetti
@es
E Falaschetti
@nl
type
label
E Falaschetti
@ast
E Falaschetti
@en
E Falaschetti
@es
E Falaschetti
@nl
prefLabel
E Falaschetti
@ast
E Falaschetti
@en
E Falaschetti
@es
E Falaschetti
@nl
P106
P31
P496
0000-0001-6964-2042